ING GROEP NV EO -,01/ NL0011821202 /
23/05/2024 12:02:08 | Chg. -0.1220 | Volume | Bid12:52:40 | Demandez à12:52:38 | Capitalisation boursière | Dividende Y. | Rapport P/E |
---|---|---|---|---|---|---|---|
16.3280EUR | -0.74% | 2,082 Chiffrre d'affaires: 34,134.9400 |
16.3800Bid taille: 920 | 16.3960Ask la taille: 920 | 54.75 Mrd.EUR | 6.75% | 7.99 |
GlobeNewswire
13:03
Unicycive Therapeutics to Participate in a Fireside Chat at the Lytham Partners Spring 2024 Investor...
GlobeNewswire
13:00
atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors
GlobeNewswire
13:00
OneMedNet Reports Greater than Five-Fold Expansion of iRWD™ Network and Platform
GlobeNewswire
13:00
Sono-Tek Announces Fiscal Year 2024 Results with Record-Breaking Revenue and Record YOY Backlog
GlobeNewswire
13:00
Hydreight Technologies through its associated Medical network now offer Tirzepatide to Product Offer...
GlobeNewswire
13:00
Leading Proxy Advisory Firm ISS Recommends that Mayfair Gold Shareholders Vote FOR All Company Nomin...
GlobeNewswire
13:00
TFF Pharmaceuticals and Leidos to Advance Next-Generation Biodefense Countermeasures Under the DARPA...
GlobeNewswire
13:00
Pyro Green-Gas Signs Contracts Totaling $1.3 Million with Global Steel Company to Desulphurize Coke ...
GlobeNewswire
13:00
Immersive Fishing and Boating Sim ‘Ships at Sea’ from Misc Games Available Now in PC Early Access
GlobeNewswire
13:00
Sandy Spring Bancorp’s Board of Directors Appoints Charles S. Cullum Chief Financial Officer
GlobeNewswire
13:00
Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Pr...
GlobeNewswire
13:00
Pneumagen Presents Positive Phase 2 Influenza Human Challenge Study data on Neumifil, its Broad-Spec...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page